{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-035814","form_type":"8-K","ticker":"EMBC","cik":"0001872789","company_name":"Embecta Corp.","filed_at":"2022-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:09.019985+00:00","generated_at":"2026-06-27T08:53:45.809234+00:00","sec_items":["1.01","2.03","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Embecta sets April 1 spin-off from BD; issues $500M senior secured notes due 2030","bullets":["BD to distribute 1 Embecta share for every 5 BD shares held on March 22, 2022; distribution expected April 1, 2022.","Embecta common stock to list on Nasdaq under symbol 'EMBC' after separation.","Embecta issued $500M of 5.000% senior secured notes due 2030, secured by assets post-spin.","Separation intended to be tax-free for BD shareholders (except cash in lieu of fractional shares).","Embecta will be independent pure-play diabetes care company; produces ~7.6B units of injection devices annually."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-035814","json":"https://secwatch.observer/filing/0001193125-22-035814.json","markdown":"https://secwatch.observer/filing/0001193125-22-035814.md","text":"https://secwatch.observer/filing/0001193125-22-035814.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1872789/000119312522035814/0001193125-22-035814-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1872789/000119312522035814/d669833d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T08:53:45.809234+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}